What Researchers Did
Researchers reported on the case of an extremely low birth weight preterm infant with purpura fulminans, detailing the diagnostic process and treatment course.
What They Found
The infant was diagnosed with purpura fulminans, protein S deficiency, and MTHFR (A1298C) and Factor V Leiden (R506Q) homozygous mutations. After failing to respond to fresh frozen plasma and unfractionated heparin, the infant showed a curative response to hyperbaric oxygen therapy.
What This Means for Canadian Patients
This case report suggests that hyperbaric oxygen therapy could be a potential treatment option for extremely low birth weight preterm infants with purpura fulminans who do not respond to conventional therapies. Patients with similar rare and severe conditions might benefit from exploring HBOT as an alternative when standard treatments are ineffective.
Canadian Relevance
This study has no direct Canadian connection as it is a single case report from outside Canada.
Study Limitations
As a single case report, the findings cannot be generalized to a broader patient population and require further validation through larger studies.